interesting that EAR making $670/Oz (plus or minus) is a buy sign for MKO who is basically being paid to treat the ore and take a smidge off the top for itself.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come